UNSW Sydney develops AI breath test for silicosis diagnosis
A team from Australia’s University of New South Wales (UNSW) Sydney has developed an AI-powered breath test for the diagnosis…
Respiratory
-
-
Leadoptik and Stanford Medicine to explore imaging in lung biopsy procedures
Leadoptik has entered a research partnership with Stanford Medicine, focusing on AI-enhanced real-time optical imaging usage in lung cancer biopsy.…
-
AccuStem Sciences acquires licence for lung cancer screening test
Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, which aims to…
-
Australia’s TGA approves Body Vision’s AI imaging system
Australia’s Therapeutic Goods Administration (TGA) has approved Body Vision Medical’s AI-powered advanced imaging system, LungVision, intended to improve the early…
-
FDA grants 510(k) clearance for Visby’s respiratory infections detection test
The US Food and Drug Administration (FDA) has granted 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for…
-
FDA clears Hologic’s Aptima SARS-CoV-2 assay
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Hologic's Aptima SARS-CoV-2 assay, marking an advancement since…
-
Australian TGA authorises marketing of Beyond Air’s LungFit PH system
The Australian Therapeutic Goods Administration (TGA) has granted authorisation to market Beyond Air’s LungFit PH as a Class IIb medical…
-
OXcan raises $11m to develop liquid biopsy tests for early cancer detection
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests…
-
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for individuals…
-
Nyxoah introduces neurostimulator device for sleep apnoea in England
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first…
